• 동위원소뉴스
• /
• no.7 s.55
• /
• pp.5-6
• /
• 2001

• Journal of Korea Society of Industrial Information Systems
• /
• v.29 no.2
• /
• pp.133-151
• /
• 2024

The purpose of this study is to analyze the core values of Donghwa Pharmaceutical, which has been in the pharmaceutical industry in South Korea for 126 years, and examine the core competencies that have consistently enabled it to maintain a competitive advantage. When applying the VRIO Framework, various general pharmaceuticals, including Donghwa Pharmaceutical's 'Hwalmyeongsoo,' which has maintained the top position in the liquid digestive medicine market for 126 years, are identified as powerful resources (Value) that generate 'sustained competitive advantage.' The principles of ethical management based on the Donghwa spirit, the long-standing principles of trust and belief, and the entrepreneurial spirit possess rarity. Having won four Guinness World Records and holding numerous new drug patents, Donghwa Pharmaceutical has consistently secured the top position in the digestive medicine category of the Korean Industrial Brand Power for 19 consecutive years. The company has been designated as a 'Golden Brand,' and its products have high levels of awareness, making them highly difficult to imitate. Lastly, the organization is structured to efficiently utilize resources such as a transparent hierarchical system, fair personnel management, diverse training programs, and high employee welfare and salaries. This study systematically analyzes the core values of Donghwa Pharmaceutical from a managerial perspective and proposes directions for the company to evolve into a long-lasting enterprise. The research outcomes will provide valuable insights for formulating long-term management strategies.

• Microbiology and Biotechnology Letters
• /
• v.16 no.5
• /
• pp.413-420
• /
• 1988

The strain capable of growing on minimal medium containing aniline as a sole source of carbon was isolated from activated sludges and identified as Pseudomonas putida biotype A. The characterizations of the strain were determined. The optimum concentration for growth of the strain was 1-20 mM of aniline. No changes of pH were detected during cultivation. Some metabolic products of biodegradation of aniline were detected after cultivation of the strain on 10 mM aniline for 48 hours. The strain showed to be resistant to streptomycin, tetracycline, trimethoprim, and sulfanilamide. The strain was also capable of utilizing other aromatic compounds related to aniline as a sole source of carbon. One plasmid carried by this strain was detected. The properties of some of the mutant strains treated with mitomycin C were also discussed. The results suggest that separate, regulatory enzyme systems capable of degrading aniline may exist in plasmid DNA.

• 동위원소뉴스
• /
• no.1 s.13
• /
• pp.4-8
• /
• 1998

• KOREAN POULTRY JOURNAL
• /
• v.37 no.7 s.429
• /
• pp.120-123
• /
• 2005

• 발명특허
• /
• v.10 no.7 s.113
• /
• pp.52-55
• /
• 1985

• KOREAN POULTRY JOURNAL
• /
• v.56 no.6
• /
• pp.120-123
• /
• 2024

• 발명특허
• /
• v.8 no.10 s.92
• /
• pp.58-59
• /
• 1983

• Biomolecules & Therapeutics
• /
• v.7 no.1
• /
• pp.59-65
• /
• 1999

A bioequivalence study of the Dong Wha Cisapril tablets(Dong Wha Pharm. Ind. Co., Ltd.) to the Prepulsid tablets(Janssen Korea Ltd.), formulations of cisapride, was conducted. Twenty four healthy Korean male subjects received each formulation at the dose of 5 mg as cisapride in a 2$\times$2 crossover study. There was a 1-week washout period between the doses. Plasma concentrations of cisapride were monitored by an LC/MS method for over a period of 36 h after each administration. AUC(area under the plasma concentration- time curve from time zero to infinity) was calculated by the linear trapezoidal and extrapolation method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma drug concentration-time data. Analysis of variance (ANOVA) revealed that there are no differences in AUC, $C_{max}$ and $T_{max}$ between the formulations. The apparent differences between the formulations in these parameters were all far less than 20% (i.e., 6.8, -6.6 and 1.8% for AUC, $C_{max}$ and $T_{max}$, respectively). Minimum detectable differences(%) at $\alpha$=0.05 and 1-$\beta$=0.8 were all less than 20% in these parameters between the formulations (i.e., 16.5, 11.4 and 16.4% for AUC, $C_{max}$ and $T_{max}$, respectively). The 90% confidence intervals for these parameters were also within 20% (i.e., -2.9~ 16.4, -13.2~0.1 and -7.8~ 11.4% for AUC, $C_{max}$ and $T_{max}$, respectively). These results satisfy the bioequivalence criteria of the Korea Food and Drug Administration (KFDA) guidelines (No. 98-51). Therefore, these results indicate that the two formulations of cisapride are bioequivalent and, thus, may be prescribed interchangeably.hangeably.y.hangeably.

• Journal of the Korean Institute of Illuminating and Electrical Installation Engineers
• /
• v.12 no.1
• /
• pp.78-84
• /
• 1998

The fluid system such as, the quantity control of raw water, chemicals control in the purification, the waste water system as well as in the feed water or circulation system of the power plant and the ventilation system is controlled with the valve and moter pump. The system's performance and the energy saving of the fluid systems depend on control of method and delicacy. Until, PI controller use in these system but it cannot control delicately because of the coupling in the system loop. In this paper we configure a single flow system to the multi variable system and suggest the application of 2-DOF PID controller and the tuning methods by the neural network to the electrical power of the flow control system. the 2-DOF controller follows to a setpoint has a robustness against the disturbance in the results of simulation. Keywords Title, Intelligent control, Neuro control, Flow control, 2 - DOF control., 2 - DOF control.